Yahoo Finance

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the "Company" or "Science 37"), the clinical research industry's leading MetasiteTM, today ...
Yahoo Finance

Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List

RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the clinical research industry-leading Metasite™, today announced that its Chief Delivery ...
MedCity News

Clinical Trials Tech Firm Science 37 to Go Private at Fraction of Past $1B Valuation

Clinical trials technology company Science 37 went public during the Covid-19 pandemic, a time when drug developers readily embraced technologies that enable patients to participate in drug studies ...
streetinsider

Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp. (LSAQ)

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. Science 37, Inc. (“Science 37”), developer of the Decentralized Clinical Trial Operating ...
Seeking Alpha

Science 37: Pioneering Decentralized Clinical Trials

Science 37 Holdings, Inc. (SNCE) is an enabler of universal access to clinical research through its Science 37 Clinical Trial Operating System ('OS), pioneering the concept of decentralized Agile ...
Nasdaq

Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future

Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial ...